Circulating 45 and 62 kDa antibodies targeting the cerebellum were previously associated with Autism Spectrum Disorder (ASD), lower adaptive/cognitive function and aberrant behaviors. Moreover, 37, 39 and 73 kDa maternal antibodies (mAb) targeting the fetal brain were previously correlated with broad autism spectrum, irritability, abnormal brain enlargement and impaired expressive language. The present study aims towards clinically characterizing individuals with brain-targeted IgG and/or exposed to maternal antibrain antibodies in a large sample of Italian autistic children (N = 355), their unaffected siblings (N = 142) and mothers (N = 333). The presence of patient-and mother-produced anti-brain antibodies does not confer increased risk of autism within the same sibship. However, the 45 and 62 kDa antibodies are correlated with autism severity: the 45 kDa Ab is associated with cognitive impairment and lower scores at the Vineland Adaptive Behavior Scales, the 62 kDa Ab with motor stereotypies, while both correlate with larger head circumference (all P < 0.05). On the other hand, maternal 37, 39 and 73 kDa antibrain antibodies, either alone or in combination, are correlated with impaired verbal and non-verbal language development, neurodevelopmental delay and sleep/wake cycle disturbances in their autistic children (P < 0.05). Presence of the 62 kDa autoAb in the child is significantly associated with presence of the 39 and/or 73 kDa antibodies in his/her mother. Our results confirm and extend previous observations in an ethnically distinct sample, providing further evidence of a pathomorphic role for antibrain antibodies in autism while demonstrating their familial clustering.
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Introduction
In recent years, several studies reported the presence of circulating IgG autoantibodies that react with components of the central nervous system (CNS) in individuals with Autism Spectrum Disorder (ASD) (Enstrom et al., 2009), a neurodevelopmental disease characterized by deficits in social reciprocity and communication, as well as by unusually restricted interests and repetitive behaviors (American Psychiatric Association, 2013) . These autoantibodies, displaying a significantly lower prevalence in population controls compared to autistic individuals (Wills et al., 2009; Goines et al., 2011) , seemingly target different brain regions, including thalamus, hypothalamus, caudate nucleus, cerebral cortex, and putamen, but most consistently the cerebellum (Cabanlit et al., 2007; Wills et al., 2007 Wills et al., , 2011 . Cerebellar specific IgG autoantibodies, initially estimated approximately 52 kDa in size and directed mainly against calretinin-positive GABAergic Golgi cells, were identified by Western Blot analysis in plasma from children with ASD (Cabanlit et al., 2007; Wills et al., 2011) . Histopathological and brain imaging studies have unveiled multiple abnormalities in the cerebellum of many autistic individuals, including a significant reduction in Purkinje cell number, cytoarchitectonic abnormalities and cytoplasmic inclusions in the deep cerebellar nuclei, and vermal hypoplasia (Fatemi et al., 2012) . At the clinical level, Goines et al. (2011) later correlated the presence of anti-cerebellar autoantibodies defined as recognizing bands at 45 and 62 kDa by western blot, with an autism diagnosis, lower adaptive and cognitive function, as well as aberrant behaviors.
